vs
Andersons, Inc.（ANDE）与Concentra Group Holdings Parent, Inc.（CON）财务数据对比。点击上方公司名可切换其他公司
Concentra Group Holdings Parent, Inc.的季度营收约是Andersons, Inc.的1.7倍（$569.6M vs $329.5M），Andersons, Inc.净利率更高（20.5% vs 9.2%，领先11.3%），Concentra Group Holdings Parent, Inc.同比增速更快（13.7% vs -2.4%），Concentra Group Holdings Parent, Inc.自由现金流更多（$9.9M vs $-77.1M）
安德森公司（The Andersons, Inc.）是1947年成立的美国农业企业，总部位于俄亥俄州莫米。公司起源于1940年代服务粮食行业的安德森货运站，是深耕农业领域的多元化企业，业务覆盖大宗商品贸易、可再生能源以及植物营养板块。
Concentra是美国的职业医疗服务商，1979年成立于得克萨斯州阿马里洛，总部位于得克萨斯州艾迪生。业务覆盖美国47个州，运营627家职业医疗中心和410个雇主驻地现场诊所，美国每7起职业伤害案例中就有1起由该机构提供诊疗服务。
ANDE vs CON — 直观对比
营收规模更大
CON
是对方的1.7倍
$329.5M
营收增速更快
CON
高出16.1%
-2.4%
净利率更高
ANDE
高出11.3%
9.2%
自由现金流更多
CON
多$87.0M
$-77.1M
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $329.5M | $569.6M |
| 净利润 | $67.4M | $52.3M |
| 毛利率 | 70.3% | — |
| 营业利润率 | 26.6% | 16.8% |
| 净利率 | 20.5% | 9.2% |
| 营收同比 | -2.4% | 13.7% |
| 净利润同比 | 49.6% | 28.7% |
| 每股收益（稀释后） | — | $0.39 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ANDECON
| Q1 26 | — | $569.6M | ||
| Q4 25 | $329.5M | $539.1M | ||
| Q3 25 | $295.8M | $572.8M | ||
| Q2 25 | $535.0M | $550.8M | ||
| Q1 25 | $370.8M | $500.8M | ||
| Q4 24 | $337.5M | — | ||
| Q3 24 | $231.9M | $489.6M | ||
| Q2 24 | $492.5M | $477.9M |
净利润ANDECON
| Q1 26 | — | $52.3M | ||
| Q4 25 | $67.4M | $34.7M | ||
| Q3 25 | $20.1M | $48.3M | ||
| Q2 25 | $7.9M | $44.6M | ||
| Q1 25 | $284.0K | $38.9M | ||
| Q4 24 | $45.1M | — | ||
| Q3 24 | $27.4M | $44.3M | ||
| Q2 24 | $36.0M | $51.7M |
毛利率ANDECON
| Q1 26 | — | — | ||
| Q4 25 | 70.3% | — | ||
| Q3 25 | 57.8% | — | ||
| Q2 25 | 29.6% | — | ||
| Q1 25 | 41.2% | — | ||
| Q4 24 | 63.1% | — | ||
| Q3 24 | 76.4% | — | ||
| Q2 24 | 35.6% | — |
营业利润率ANDECON
| Q1 26 | — | 16.8% | ||
| Q4 25 | 26.6% | 12.9% | ||
| Q3 25 | 8.7% | 16.5% | ||
| Q2 25 | 4.6% | 16.3% | ||
| Q1 25 | 0.9% | 16.0% | ||
| Q4 24 | 19.9% | — | ||
| Q3 24 | 26.8% | 17.6% | ||
| Q2 24 | 11.6% | 17.6% |
净利率ANDECON
| Q1 26 | — | 9.2% | ||
| Q4 25 | 20.5% | 6.4% | ||
| Q3 25 | 6.8% | 8.4% | ||
| Q2 25 | 1.5% | 8.1% | ||
| Q1 25 | 0.1% | 7.8% | ||
| Q4 24 | 13.4% | — | ||
| Q3 24 | 11.8% | 9.1% | ||
| Q2 24 | 7.3% | 10.8% |
每股收益（稀释后）ANDECON
| Q1 26 | — | $0.39 | ||
| Q4 25 | — | $0.27 | ||
| Q3 25 | $0.59 | $0.38 | ||
| Q2 25 | $0.23 | $0.35 | ||
| Q1 25 | $0.01 | $0.30 | ||
| Q4 24 | $1.31 | — | ||
| Q3 24 | $0.80 | $0.37 | ||
| Q2 24 | $1.05 | $0.50 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $98.3M | — |
| 总债务越低越好 | $560.0M | $1.6B |
| 股东权益账面价值 | $1.2B | $424.7M |
| 总资产 | $3.7B | $2.9B |
| 负债/权益比越低杠杆越低 | 0.45× | 3.68× |
8季度趋势，按日历期对齐
现金及短期投资ANDECON
| Q1 26 | — | — | ||
| Q4 25 | $98.3M | $79.9M | ||
| Q3 25 | — | $49.9M | ||
| Q2 25 | — | $73.9M | ||
| Q1 25 | — | $52.1M | ||
| Q4 24 | $561.8M | — | ||
| Q3 24 | — | $136.8M | ||
| Q2 24 | — | $50.7M |
总债务ANDECON
| Q1 26 | — | $1.6B | ||
| Q4 25 | $560.0M | $1.6B | ||
| Q3 25 | — | $1.6B | ||
| Q2 25 | — | $1.7B | ||
| Q1 25 | — | $1.6B | ||
| Q4 24 | $608.2M | — | ||
| Q3 24 | — | $1.5B | ||
| Q2 24 | — | $3.0M |
股东权益ANDECON
| Q1 26 | — | $424.7M | ||
| Q4 25 | $1.2B | $393.3M | ||
| Q3 25 | $1.2B | $385.5M | ||
| Q2 25 | $1.4B | $342.6M | ||
| Q1 25 | $1.4B | $307.1M | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $1.3B | $277.8M | ||
| Q2 24 | $1.3B | $1.2B |
总资产ANDECON
| Q1 26 | — | $2.9B | ||
| Q4 25 | $3.7B | $2.9B | ||
| Q3 25 | $3.3B | $2.8B | ||
| Q2 25 | $3.4B | $2.8B | ||
| Q1 25 | $3.8B | $2.7B | ||
| Q4 24 | $4.1B | — | ||
| Q3 24 | $3.4B | $2.5B | ||
| Q2 24 | $3.3B | $2.4B |
负债/权益比ANDECON
| Q1 26 | — | 3.68× | ||
| Q4 25 | 0.45× | 3.98× | ||
| Q3 25 | — | 4.15× | ||
| Q2 25 | — | 4.82× | ||
| Q1 25 | — | 5.27× | ||
| Q4 24 | 0.45× | — | ||
| Q3 24 | — | 5.30× | ||
| Q2 24 | — | 0.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-6.2M | $21.0M |
| 自由现金流经营现金流 - 资本支出 | $-77.1M | $9.9M |
| 自由现金流率自由现金流/营收 | -23.4% | 1.7% |
| 资本支出强度资本支出/营收 | 21.5% | — |
| 现金转化率经营现金流/净利润 | -0.09× | 0.40× |
| 过去12个月自由现金流最近4个季度 | $-56.1M | $211.0M |
8季度趋势，按日历期对齐
经营现金流ANDECON
| Q1 26 | — | $21.0M | ||
| Q4 25 | $-6.2M | $118.7M | ||
| Q3 25 | $233.9M | $60.6M | ||
| Q2 25 | $299.3M | $88.4M | ||
| Q1 25 | $-350.0M | $11.7M | ||
| Q4 24 | $268.8M | — | ||
| Q3 24 | $-2.1M | $65.9M | ||
| Q2 24 | $304.4M | — |
自由现金流ANDECON
| Q1 26 | — | $9.9M | ||
| Q4 25 | $-77.1M | $98.5M | ||
| Q3 25 | $167.0M | $39.4M | ||
| Q2 25 | $250.5M | $63.2M | ||
| Q1 25 | $-396.6M | $-4.0M | ||
| Q4 24 | $212.9M | — | ||
| Q3 24 | $-40.0M | $50.8M | ||
| Q2 24 | $275.8M | — |
自由现金流率ANDECON
| Q1 26 | — | 1.7% | ||
| Q4 25 | -23.4% | 18.3% | ||
| Q3 25 | 56.5% | 6.9% | ||
| Q2 25 | 46.8% | 11.5% | ||
| Q1 25 | -106.9% | -0.8% | ||
| Q4 24 | 63.1% | — | ||
| Q3 24 | -17.2% | 10.4% | ||
| Q2 24 | 56.0% | — |
资本支出强度ANDECON
| Q1 26 | — | — | ||
| Q4 25 | 21.5% | 3.7% | ||
| Q3 25 | 22.6% | 3.7% | ||
| Q2 25 | 9.1% | 4.6% | ||
| Q1 25 | 12.6% | 3.1% | ||
| Q4 24 | 16.6% | — | ||
| Q3 24 | 16.3% | 3.1% | ||
| Q2 24 | 5.8% | — |
现金转化率ANDECON
| Q1 26 | — | 0.40× | ||
| Q4 25 | -0.09× | 3.42× | ||
| Q3 25 | 11.61× | 1.26× | ||
| Q2 25 | 38.10× | 1.98× | ||
| Q1 25 | -1232.46× | 0.30× | ||
| Q4 24 | 5.96× | — | ||
| Q3 24 | -0.08× | 1.49× | ||
| Q2 24 | 8.46× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ANDE
| Specialty And Primary Nutrients | $137.1M | 42% |
| Premium Ingredients | $66.1M | 20% |
| Segment Reporting Reconciling Item Other | $63.2M | 19% |
| Other | $63.1M | 19% |
CON
| Workers' compensation | $337.7M | 59% |
| Employer services | $172.4M | 30% |
| Onsite health clinics | $37.2M | 7% |
| Other | $14.5M | 3% |
| Consumer health | $7.8M | 1% |
